Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · IEX Real-Time Price · USD
9.47
+0.49 (5.46%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Third Harmonic Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
19.9913.33.261.17
Research & Development
23.9624.4115.759.95
Operating Expenses
43.9537.711911.12
Operating Income
-43.95-37.71-19-11.12
Other Expense / Income
-13.13-2.5510.611.69
Pretax Income
-30.82-35.16-29.61-12.81
Net Income
-30.82-35.16-29.61-12.81
Shares Outstanding (Basic)
401448
Shares Outstanding (Diluted)
401448
Shares Change
176.21%254.97%-51.20%-
EPS (Basic)
-0.78-2.45-7.32-1.55
EPS (Diluted)
-0.78-2.45-7.32-1.55
Free Cash Flow
-20.59-34.95-15.75-9.19
Free Cash Flow Per Share
-0.52-2.44-3.89-1.11
EBITDA
-30.23-35.12-29.61-12.81
Depreciation & Amortization
0.60.0400
EBIT
-30.82-35.16-29.61-12.81
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).